Abstract
Fragile X syndrome, an X-linked genetic disorder, is the third most common cause of mental retardation. The following is a case of a 6-year-old boy with fragile X syndrome and its characteristic cognitive and behavioral symptomatology, including attention deficit hyperactivity disorder. In addition, this child experienced initial insomnia and nocturnal enuresis, problems not previously reported with fragile X. Previous pharmacological treatment of the syndrome's behavioral difficulties and attention deficit has included stimulants, folic acid, and neuroleptics. This is the first report of the successful use of imipramine. Imipramine also improved the boy's insomnia and enuresis, whereas methylphenidate caused an overall worsening of his condition.
| Original language | English |
|---|---|
| Pages (from-to) | 831-834 |
| Number of pages | 4 |
| Journal | Journal of the American Academy of Child and Adolescent Psychiatry |
| Volume | 30 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1991 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ADHD
- Martin-Bell syndrome
- fragile X syndrome
- imipramine
ASJC Scopus subject areas
- Developmental and Educational Psychology
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'Imipramine treatment of ADHD in a fragile X child'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver